Angiotensin II receptor blocker inhibits p27Kip1 expression in glucose-stimulated podocytes and in diabetic glomeruli
about
A novel mutation in BBS7 gene causes Bardet-Biedl syndrome in a Chinese familyNovel role of parathyroid hormone-related protein in the pathophysiology of the diabetic kidney: evidence from experimental and human diabetic nephropathyRenal stem cells: fact or science fiction?Advanced glycated end-products affect HIF-transcriptional activity in renal cellsActivation of local aldosterone system within podocytes is involved in apoptosis under diabetic conditions.The MCP-1/CCR2 axis in podocytes is involved in apoptosis induced by diabetic conditions.Epac1-mediated, high glucose-induced renal proximal tubular cells hypertrophy via the Akt/p21 pathwayPodocyte hypertrophy precedes apoptosis under experimental diabetic conditions.Intracardiac intracellular angiotensin system in diabetes.Follistatin-like 3 suppresses cell proliferation and fibronectin expression via p38MAPK pathway in rat mesangial cells cultured under high glucoseMycophenolate mofetil inhibits hypertrophy and apoptosis of podocyte in vivo and in vitro.Angiotensin II blockade and renal protection.Regenerative medicine for the kidney: stem cell prospects & challenges.12-Lipoxygenase Inhibition on Microalbuminuria in Type-1 and Type-2 Diabetes Is Associated with Changes of Glomerular Angiotensin II Type 1 Receptor Related to Insulin Resistance.Glomerular cell death and inflammation with high-protein diet and diabetesPodocyte repopulation contributes to regression of glomerular injury induced by ACE inhibition.A transgenic mouse model for studying the role of the parathyroid hormone-related protein system in renal injury.Clinicopathological characteristics of obesity-associated focal segmental glomerulosclerosis.Renin-angiotensin system within the diabetic podocyte.Urinary angiotensin converting enzyme 2 is strongly related to urinary nephrin in type 2 diabetes patients.The influence of high glucose on the Cip/Kip family expression profiles in HRECs.Redox dependence of glomerular epithelial cell hypertrophy in response to glucose.Activation of a local renin angiotensin system in podocytes by glucose.Advanced glycation end-products induce cell cycle arrest and hypertrophy in podocytes.Apoptosis occurs differentially according to glomerular size in diabetic kidney disease.The locally activated renin-angiotensin system is involved in albumin permeability in glomerular endothelial cells under high glucose conditions.Local kallikrein-kinin system is involved in podocyte apoptosis under diabetic conditions.Translationally controlled tumour protein is associated with podocyte hypertrophy in a mouse model of type 1 diabetes.
P2860
Q24644846-BE93015B-2BA2-45FF-8047-A55D1D91AE4AQ26862757-C55748ED-4031-4518-8803-5998A5DA202CQ27006064-45620394-A740-4386-A471-8B6234F9408AQ28591845-9AFBF073-E1F0-4EB8-BD30-70384D6F204BQ33497107-F8963883-55CB-4425-87E8-229635EF3163Q34050210-91E2B989-0F1E-4117-B6C4-228F1B00E4A1Q35235683-905AA793-7A49-4DC4-B3E0-F694BBF62B9BQ35624799-613D257F-A339-43DA-BFB5-83A958B5189FQ35850260-05E7D516-C287-4C64-B222-D901563205CDQ36317463-60561D50-4608-437D-A301-1DA6F0353C42Q36412461-A7A5BF52-888A-4CB3-AEE8-9EBB781DAAB9Q36836004-F276DC58-79A3-4010-9798-285B138A168EQ36880911-637E4311-D8DB-4A84-882E-911C27FCC7D6Q36939224-C7E6FE2F-F2C7-437E-9902-64BBBB2A34B3Q37000229-3F983F27-B670-459F-868F-573EDB926422Q37150757-706BF606-97E6-4AB7-A5FA-115146AA644AQ37807262-2D24C04D-B30C-427A-B3E4-2D742D9BEAF1Q37886981-92CD6C7E-93AA-4B05-8EDD-D718F88E7CEEQ38262105-71B00DB0-741D-40AC-8756-3771D1925ACDQ39676702-90682808-14D0-45A6-A489-D2C5AE49C018Q45765775-104EDE50-1E2D-4D57-934D-9B9C3BB1CB54Q46761417-484829E4-8FE6-4AE8-B1F7-E5823D25A204Q46794009-46CFF7C5-3823-4202-834E-40A7F9098FA9Q46870317-E95073A9-3F5E-4492-B754-2EA84BF4C772Q47372589-FBABAB80-44C2-4DB7-B3BB-8ED7668FFC9BQ48649007-B68196D1-4715-4D5E-9BE0-01216774AD29Q53435442-55E1CBAC-E120-4D72-B832-C02280C26D7FQ53669187-EFEFBA64-B1E6-4252-A6F5-95BC68DFCC02
P2860
Angiotensin II receptor blocker inhibits p27Kip1 expression in glucose-stimulated podocytes and in diabetic glomeruli
description
2005 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի մարտին հրատարակված գիտական հոդված
@hy
artículu científicu espublizáu en 2005
@ast
im März 2005 veröffentlichter wissenschaftlicher Artikel
@de
scientific journal article
@en
vedecký článok (publikovaný 2005/03/01)
@sk
vědecký článek publikovaný v roce 2005
@cs
wetenschappelijk artikel (gepubliceerd op 2005/03/01)
@nl
наукова стаття, опублікована в березні 2005
@uk
مقالة علمية (نشرت في مارس 2005)
@ar
name
Angiotensin II receptor blocke ...... ytes and in diabetic glomeruli
@ast
Angiotensin II receptor blocke ...... ytes and in diabetic glomeruli
@en
Angiotensin II receptor blocke ...... ytes and in diabetic glomeruli
@nl
type
label
Angiotensin II receptor blocke ...... ytes and in diabetic glomeruli
@ast
Angiotensin II receptor blocke ...... ytes and in diabetic glomeruli
@en
Angiotensin II receptor blocke ...... ytes and in diabetic glomeruli
@nl
prefLabel
Angiotensin II receptor blocke ...... ytes and in diabetic glomeruli
@ast
Angiotensin II receptor blocke ...... ytes and in diabetic glomeruli
@en
Angiotensin II receptor blocke ...... ytes and in diabetic glomeruli
@nl
P2093
P50
P3181
P1433
P1476
Angiotensin II receptor blocke ...... ytes and in diabetic glomeruli
@en
P2093
Dae Suk Han
Hyeong Cheon Park
Rama Natarajan
Sharon G Adler
Sung Kyu Ha
Zhong-Gao Xu
P304
P3181
P356
10.1111/J.1523-1755.2005.00158.X
P407
P577
2005-03-01T00:00:00Z
P5875
P6179
1042634403